(+)-catechin multiple interactions ISO RGD:1322895 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of CTNNAL1 mRNA CTD PMID:24763279 (-)-demecolcine decreases expression ISO RGD:1322895 6480464 Demecolcine results in decreased expression of CTNNAL1 mRNA CTD PMID:23649840 1,1-dichloroethene decreases expression ISO RGD:1553734 6480464 vinylidene chloride results in decreased expression of CTNNAL1 mRNA CTD PMID:26682919 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553734 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNAL1 mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1553734 6480464 Tetrachlorodibenzodioxin results in decreased expression of CTNNAL1 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553734 6480464 Tetrachlorodibenzodioxin affects the expression of CTNNAL1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CTNNAL1 mRNA CTD PMID:22298810 , PMID:34747641 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CTNNAL1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CTNNAL1 mRNA CTD PMID:21346803 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of CTNNAL1 mRNA CTD PMID:21061450 4-hydroxyphenyl retinamide decreases expression ISO RGD:1553734 6480464 Fenretinide results in decreased expression of CTNNAL1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CTNNAL1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CTNNAL1 mRNA CTD PMID:30047161 acrolein multiple interactions ISO RGD:1322895 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTNNAL1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTNNAL1 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:1322895 6480464 Acrylamide results in increased expression of CTNNAL1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1553734 6480464 Aflatoxin B1 results in increased expression of CTNNAL1 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:1322895 6480464 Aflatoxin B1 results in increased expression of CTNNAL1 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:1322895 6480464 Aflatoxin B1 results in decreased methylation of CTNNAL1 gene CTD PMID:27153756 Aflatoxin B2 alpha decreases methylation ISO RGD:1322895 6480464 aflatoxin B2 results in decreased methylation of CTNNAL1 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1322895 6480464 Tretinoin results in decreased expression of CTNNAL1 mRNA CTD PMID:15498508 , PMID:33167477 alpha-pinene multiple interactions ISO RGD:1322895 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTNNAL1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTNNAL1 mRNA CTD PMID:32699268 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of CTNNAL1 mRNA CTD PMID:30047161 antimycin A increases expression ISO RGD:1322895 6480464 Antimycin A results in increased expression of CTNNAL1 mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:1322895 6480464 aristolochic acid I results in decreased expression of CTNNAL1 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1322895 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CTNNAL1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1322895 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CTNNAL1 mRNA CTD PMID:32525701 arsenous acid increases expression ISO RGD:1322895 6480464 Arsenic Trioxide results in increased expression of CTNNAL1 mRNA CTD PMID:22521957 atrazine increases expression ISO RGD:1322895 6480464 Atrazine results in increased expression of CTNNAL1 mRNA CTD PMID:22378314 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA CTD PMID:33854195 benzo[a]pyrene increases expression ISO RGD:1322895 6480464 Benzo(a)pyrene results in increased expression of CTNNAL1 mRNA CTD PMID:32234424 benzo[e]pyrene decreases methylation ISO RGD:1322895 6480464 benzo(e)pyrene results in decreased methylation of CTNNAL1 intron CTD PMID:30157460 beta-carotene multiple interactions ISO RGD:1553734 6480464 [BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of CTNNAL1 mRNA CTD PMID:24657404 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CTNNAL1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1553734 6480464 bisphenol A results in increased expression of CTNNAL1 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CTNNAL1 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO RGD:1322895 6480464 bisphenol A results in decreased expression of CTNNAL1 mRNA CTD PMID:29275510 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CTNNAL1 mRNA CTD PMID:33453195 cadmium dichloride increases expression ISO RGD:1322895 6480464 Cadmium Chloride results in increased expression of CTNNAL1 mRNA CTD PMID:26472689 caffeine increases phosphorylation ISO RGD:1322895 6480464 Caffeine results in increased phosphorylation of CTNNAL1 protein CTD PMID:35688186 carbon nanotube decreases expression ISO RGD:1553734 6480464 Nanotubes, Carbon analog results in decreased expression of CTNNAL1 mRNA CTD PMID:25554681 carmustine increases expression ISO RGD:1322895 6480464 Carmustine results in increased expression of CTNNAL1 mRNA CTD PMID:15980968 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CTNNAL1 mRNA CTD PMID:30744511 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA CTD PMID:33854195 chromium(6+) affects expression ISO RGD:1553734 6480464 chromium hexavalent ion affects the expression of CTNNAL1 mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:1322895 6480464 Cisplatin results in increased expression of CTNNAL1 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1322895 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CTNNAL1 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1322895 6480464 Cisplatin results in decreased expression of CTNNAL1 mRNA CTD PMID:27392435 cisplatin affects response to substance ISO RGD:1322895 6480464 CTNNAL1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clobetasol decreases expression ISO RGD:1553734 6480464 Clobetasol results in decreased expression of CTNNAL1 mRNA CTD PMID:27462272 copper atom increases expression EXP 6480464 Copper results in increased expression of CTNNAL1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of CTNNAL1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1322895 6480464 Copper Sulfate results in increased expression of CTNNAL1 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1322895 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 coumestrol increases expression ISO RGD:1322895 6480464 Coumestrol results in increased expression of CTNNAL1 mRNA CTD PMID:19167446 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CTNNAL1 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1322895 6480464 Cyclosporine results in increased expression of CTNNAL1 mRNA CTD PMID:20106945 more ... deguelin increases expression ISO RGD:1322895 6480464 deguelin results in increased expression of CTNNAL1 mRNA CTD PMID:33512557 diarsenic trioxide increases expression ISO RGD:1322895 6480464 Arsenic Trioxide results in increased expression of CTNNAL1 mRNA CTD PMID:22521957 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CTNNAL1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1553734 6480464 Dibutyl Phthalate results in increased expression of CTNNAL1 mRNA CTD PMID:17361019 dicrotophos decreases expression ISO RGD:1322895 6480464 dicrotophos results in decreased expression of CTNNAL1 mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CTNNAL1 mRNA CTD PMID:21551480 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CTNNAL1 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1322895 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA CTD PMID:19167446 fenpyroximate increases expression ISO RGD:1322895 6480464 fenpyroximate results in increased expression of CTNNAL1 mRNA CTD PMID:33512557 fenthion decreases expression ISO RGD:1553734 6480464 Fenthion results in decreased expression of CTNNAL1 mRNA CTD PMID:34813904 fulvestrant increases methylation ISO RGD:1322895 6480464 Fulvestrant results in increased methylation of CTNNAL1 gene CTD PMID:31601247 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA CTD PMID:33854195 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA CTD PMID:33854195 isoprenaline increases expression ISO RGD:1553734 6480464 Isoproterenol results in increased expression of CTNNAL1 mRNA CTD PMID:20003209 kojic acid decreases expression ISO RGD:1322895 6480464 kojic acid results in decreased expression of CTNNAL1 mRNA CTD PMID:16595896 methapyrilene decreases methylation ISO RGD:1322895 6480464 Methapyrilene results in decreased methylation of CTNNAL1 intron CTD PMID:30157460 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of CTNNAL1 mRNA CTD PMID:30047161 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CTNNAL1 mRNA CTD PMID:30744511 mifepristone increases expression ISO RGD:1322895 6480464 Mifepristone results in increased expression of CTNNAL1 mRNA CTD PMID:17584828 morphine increases expression ISO RGD:1553734 6480464 Morphine results in increased expression of CTNNAL1 mRNA CTD PMID:21178816 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CTNNAL1 mRNA CTD PMID:28801915 nickel sulfate decreases expression ISO RGD:1322895 6480464 nickel sulfate results in decreased expression of CTNNAL1 mRNA CTD PMID:22714537 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of CTNNAL1 mRNA CTD PMID:33484710 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CTNNAL1 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1322895 6480464 Ozone results in increased expression of CTNNAL1 mRNA CTD PMID:23033980 , PMID:28652203 ozone increases expression EXP 6480464 Ozone results in increased expression of CTNNAL1 mRNA CTD PMID:23000764 ozone multiple interactions ISO RGD:1553734 6480464 Ozone promotes the reaction [[LEF1 protein binds to CTNNAL1 protein] which results in increased expression of CTNNAL1 mRNA], Ozone promotes the reaction [[TFAP2A protein binds to CTNNAL1 protein] which results in increased expression of CTNNAL1 mRNA] CTD PMID:22359570 ozone increases expression ISO RGD:1553734 6480464 Ozone results in increased expression of CTNNAL1 mRNA CTD PMID:22359570 ozone multiple interactions ISO RGD:1322895 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTNNAL1 mRNA more ... CTD PMID:29791759 , PMID:32699268 paracetamol decreases expression ISO RGD:1322895 6480464 Acetaminophen results in decreased expression of CTNNAL1 mRNA CTD PMID:26690555 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CTNNAL1 mRNA CTD PMID:33387578 perfluorooctanoic acid decreases expression ISO RGD:1322895 6480464 perfluorooctanoic acid results in decreased expression of CTNNAL1 protein CTD PMID:26879310 phenobarbital affects expression ISO RGD:1322895 6480464 Phenobarbital affects the expression of CTNNAL1 mRNA CTD PMID:19159669 picoxystrobin increases expression ISO RGD:1322895 6480464 picoxystrobin results in increased expression of CTNNAL1 mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:1553734 6480464 pirinixic acid results in increased expression of CTNNAL1 mRNA CTD PMID:18301758 , PMID:23811191 piroxicam decreases expression ISO RGD:1322895 6480464 Piroxicam results in decreased expression of CTNNAL1 mRNA CTD PMID:21858171 potassium dichromate affects expression ISO RGD:1553734 6480464 Potassium Dichromate affects the expression of CTNNAL1 mRNA CTD PMID:23608068 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of CTNNAL1 mRNA CTD PMID:30047161 pyrogallol decreases expression ISO RGD:1553734 6480464 Pyrogallol results in decreased expression of CTNNAL1 mRNA CTD PMID:20362636 resveratrol multiple interactions ISO RGD:1322895 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CTNNAL1 mRNA CTD PMID:19167446 silicon dioxide increases expression ISO RGD:1322895 6480464 Silicon Dioxide analog results in increased expression of CTNNAL1 mRNA CTD PMID:25895662 simvastatin decreases expression ISO RGD:1322895 6480464 Simvastatin results in decreased expression of CTNNAL1 mRNA CTD PMID:17428261 sodium arsenate multiple interactions ISO RGD:1322895 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CTNNAL1 mRNA CTD PMID:32525701 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of CTNNAL1 mRNA CTD PMID:30047161 tamibarotene decreases expression ISO RGD:1322895 6480464 tamibarotene results in decreased expression of CTNNAL1 mRNA CTD PMID:15498508 temozolomide decreases expression ISO RGD:1322895 6480464 Temozolomide results in decreased expression of CTNNAL1 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:1553734 6480464 Testosterone deficiency results in increased expression of CTNNAL1 mRNA CTD PMID:33848595 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CTNNAL1 mRNA CTD PMID:31150632 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA CTD PMID:33854195 titanium dioxide decreases expression ISO RGD:1553734 6480464 titanium dioxide results in decreased expression of CTNNAL1 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CTNNAL1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CTNNAL1 mRNA CTD PMID:25729387 valproic acid affects expression ISO RGD:1322895 6480464 Valproic Acid affects the expression of CTNNAL1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1322895 6480464 Valproic Acid results in increased expression of CTNNAL1 mRNA CTD PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CTNNAL1 mRNA CTD PMID:23869203 vincristine decreases expression ISO RGD:1322895 6480464 Vincristine results in decreased expression of CTNNAL1 mRNA CTD PMID:23649840